An association of Ephedra use with psychosis and autonomic hyperactivity

Ephedra extract is used in a number of dietary supplements taken for a variety of purposes including weight loss. Although recent events have led to calls for Ephedra to be removed from the market and the FDA has had over 18,000 adverse event reports, newspaper reports cite only a few instances of c...

Full description

Saved in:
Bibliographic Details
Published inAnnals of clinical psychiatry Vol. 16; no. 3; p. 167
Main Authors Philibert, Robert, Mac, Joseph
Format Journal Article
LanguageEnglish
Published United States 01.07.2004
Subjects
Adult
Autonomic Nervous System - drug effects
Ephedra - adverse effects
Female
Hospitalization
Humans
Hyperkinesis - drug therapy
Hyperkinesis - etiology
Hyperkinesis - rehabilitation
Psychotic Disorders - etiology
Psychotic Disorders - rehabilitation
Severity of Illness Index
Online AccessGet more information

Cover

More Information
Summary:Ephedra extract is used in a number of dietary supplements taken for a variety of purposes including weight loss. Although recent events have led to calls for Ephedra to be removed from the market and the FDA has had over 18,000 adverse event reports, newspaper reports cite only a few instances of clearly associated adverse events associated with Ephedra use. In this communication, we review the literature and present a case report of Ephedra use associated with the onset of psychosis and autonomic hyperactivity after administration of risperidone. We conclude that the behavioral effects of Ephedra are a public health concern.
ISSN:1040-1237
DOI:10.1080/10401230490487043